FFAR2 has been reported to have significantly reduced expression in colorectal adenocarcinoma, and propionate, the ligand for FFAR2 and FFAR3, is shown to reduce proliferation and promote apoptosis in several cancer cell types [26, 30–33]. This evidence concerns the gene FFAR2 and colorectal adenocarcinoma.